Never before in the history of modern healthcare has the industry been so ripe for fundamental, strategic disruption. Some of it forced at the hands of regulators, some by market dynamics, some by the need to improve the fundamentals of cost and quality. The question isn’t whether it will happen, because it’s happening now. The question is how ready are healthcare payers, hospitals, ambulatory surgery centers, surgeons, manufacturers and patients for the disruption headed their way on the implantable medical device front.
To read the rest of the article, visit Becker’s Hospital Review.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
